Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2014 (2014), Article ID 247637, 8 pages
http://dx.doi.org/10.1155/2014/247637
Research Article

A Promoter Region Polymorphism in PDCD-1 Gene Is Associated with Risk of Rheumatoid Arthritis in the Han Chinese Population of Southeastern China

1Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
2Medical Biotechnology Institute, Soochow University, Suzhou 215006, China
3Wuxi Red Cross Blood Center, Wuxi 214021, China
4Testing Center, Center for Disease Prevention and Control, Changzhou 213000, China
5Department of Dermatology, First Hospital, Peking University, Beijing 100034, China

Received 21 January 2014; Revised 10 March 2014; Accepted 11 March 2014; Published 3 April 2014

Academic Editor: Ji-Fu Wei

Copyright © 2014 CuiPing Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  2. L. Klareskog, A. I. Catrina, and S. Paget, “Rheumatoid arthritis,” The Lancet, vol. 373, no. 9664, pp. 659–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England Journal of Medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Google Scholar · View at Scopus
  4. M. Gol-Ara, F. Jadidi-Niaragh, R. Sadria et al., “The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis,” Arthritis, vol. 2012, Article ID 805875, 16 pages, 2012. View at Publisher · View at Google Scholar
  5. M. E. Keir, M. J. Butte, G. J. Freeman, and A. H. Sharpe, “PD-1 and its ligands in tolerance and immunity,” Annual Review of Immunology, vol. 26, pp. 677–704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Francisco, P. T. Sage, and A. H. Sharpe, “The PD-1 pathway in tolerance and autoimmunity,” Immunological Reviews, vol. 236, no. 1, pp. 219–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. V. Parry, J. M. Chemnitz, K. A. Frauwirth et al., “CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms,” Molecular and Cellular Biology, vol. 25, no. 21, pp. 9543–9553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Wang, T. Yoshida, F. Nakaki, H. Hiai, T. Okazaki, and T. Honjo, “Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 33, pp. 11823–11828, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Nishimura, M. Nose, H. Hiai, N. Minato, and T. Honjo, “Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor,” Immunity, vol. 11, no. 2, pp. 141–151, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Okazaki and T. Honjo, “PD-1 and PD-1 ligands: from discovery to clinical application,” International Immunology, vol. 19, no. 7, pp. 813–824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. K. Bertsias, M. Nakou, C. Choulaki et al., “Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 60, no. 1, pp. 207–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Prokunina, L. Padyukov, A. Bennet et al., “Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope,” Arthritis and Rheumatism, vol. 50, no. 6, pp. 1770–1773, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. K. Kong, L. Prokunina-Olsson, W. H. Wong et al., “A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese,” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1058–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kroner, M. Mehling, B. Hemmer et al., “A PD-1 polymorphism is associated with disease progression in multiple sclerosis,” Annals of Neurology, vol. 58, no. 1, pp. 50–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Nielsen, D. Hansen, S. Husby, B. B. Jacobsen, and S. T. Lillevang, “Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes,” Tissue Antigens, vol. 62, no. 6, pp. 492–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Ni, K. Ihara, K. Miyako et al., “PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children,” Human Genetics, vol. 121, no. 2, pp. 223–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Keir, S. C. Liang, I. Guleria et al., “Tissue expression of PD-L1 mediates peripheral T cell tolerance,” Journal of Experimental Medicine, vol. 203, no. 4, pp. 883–895, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. B. T. Fife, I. Guleria, M. G. Bupp et al., “Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway,” Journal of Experimental Medicine, vol. 203, no. 12, pp. 2737–2747, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. T. Fife, K. E. Pauken, T. N. Eagar et al., “Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal,” Nature Immunology, vol. 10, no. 11, pp. 1185–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Wang, P. Hu, J. Yang, G. Shen, and X. Wu, “The effects of PDL-Ig on collagen-induced arthritis,” Rheumatology International, vol. 31, no. 4, pp. 513–519, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Raptopoulou, G. Bertsias, D. Makrygiannakis et al., “The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis,” Arthritis and Rheumatism, vol. 62, no. 7, pp. 1870–1880, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Prokunina, C. Castillejo-López, F. Öberg et al., “A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans,” Nature Genetics, vol. 32, no. 4, pp. 666–669, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Wang, Y. Chen, T. Ou et al., “Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan,” Journal of Clinical Immunology, vol. 26, no. 6, pp. 506–511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Meng, X. Liu, P. Yang et al., “PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome,” Molecular Vision, vol. 15, pp. 386–392, 2009. View at Google Scholar · View at Scopus
  25. K. M. K. de Vooght and W. W. van Solinge, “Gene promoter analysis in molecular diagnostics: do or don't?” Expert Review of Molecular Diagnostics, vol. 9, no. 5, pp. 403–405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. T. Tahoori, A. A. Pourfathollah, M. Akhlaghi, S. Daneshmandi, M. H. Nicknam, and N. Soleimanifar, “Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients,” Clinical and Experimental Rheumatology, vol. 29, no. 5, pp. 763–767, 2011. View at Google Scholar · View at Scopus
  27. Z. Hua, D. Li, F. Xu et al., “PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China,” Breast Cancer Research and Treatment, vol. 129, no. 1, pp. 195–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. J. Khoury and M. H. Sayegh, “The roles of the new negative T cell costimulatory pathways in regulating autoimmunity,” Immunity, vol. 20, no. 5, pp. 529–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Okazaki and T. Honjo, “The PD-1-PD-L pathway in immunological tolerance,” Trends in Immunology, vol. 27, no. 4, pp. 195–201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Martin-Orozco, Y. Wang, H. Yagita, and C. Dong, “Cutting edge: programed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens,” Journal of Immunology, vol. 177, no. 12, pp. 8291–8295, 2006. View at Google Scholar · View at Scopus
  31. S. Hatachi, Y. Iwai, S. Kawano et al., “CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid,” Journal of Rheumatology, vol. 30, no. 7, pp. 1410–1419, 2003. View at Google Scholar · View at Scopus